Main > ONCOLOGY (**) > NeuroBlastoma > TREAT.: > USA. Y. NaxitaMAb gqgk+>

---

USA. Y. NaxitaMAb gqgk+>'s subsections
(*) USA Approval Date: 2020. 11.25.
+GM-CSF
>R/R
Company
Patent>Assignee; Claims; No.; Etc.
Patent>UpDate: 2021. 02.23.
TradeMark
TradeMark Web-Site

USA. Y. NaxitaMAb gqgk+>'s products
This section has no products